Ronald Blue Trust, Inc. Omeros Corp Transaction History
Ronald Blue Trust, Inc.
- $7.98 Billion
- Q3 2024
A detailed history of Ronald Blue Trust, Inc. transactions in Omeros Corp stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 5,000 shares of OMER stock, worth $45,900. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,000
Previous 5,000
-0.0%
Holding current value
$45,900
Previous $20,000
5.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding OMER
# of Institutions
122Shares Held
25.6MCall Options Held
228KPut Options Held
630K-
Ingalls & Snyder LLC New York, NY4.54MShares$41.7 Million0.7% of portfolio
-
Black Rock Inc. New York, NY4.1MShares$37.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.26MShares$29.9 Million0.0% of portfolio
-
Stifel Financial Corp St. Louis, MO1.9MShares$17.5 Million0.01% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.61MShares$14.7 Million0.01% of portfolio
About OMEROS CORP
- Ticker OMER
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,730,000
- Market Cap $576M
- Description
- Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...